SLI
|
1’653.46
|
6.52
|
0.40%
|
Analysen zu SLI-Werten
| 24.11.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.11.20 | ams overweight | JP Morgan Chase & Co. | |
| 24.11.20 | Swiss Re overweight | Barclays Capital | |
| 23.11.20 | Swiss Re buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.11.20 | UBS overweight | JP Morgan Chase & Co. | |
| 20.11.20 | ABB (Asea Brown Boveri overweight | Barclays Capital | |
| 20.11.20 | Swiss Re Outperform | RBC Capital Markets | |
| 20.11.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 20.11.20 | ABB (Asea Brown Boveri buy | UBS AG | |
| 19.11.20 | ABB (Asea Brown Boveri Sector Perform | RBC Capital Markets | |
| 19.11.20 | ABB (Asea Brown Boveri Underweight | JP Morgan Chase & Co. | |
| 19.11.20 | ABB (Asea Brown Boveri Underweight | JP Morgan Chase & Co. | |
| 19.11.20 | ABB (Asea Brown Boveri Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.11.20 | ABB (Asea Brown Boveri Underperform | Jefferies & Company Inc. | |
| 19.11.20 | Givaudan Underweight | Barclays Capital | |
| 18.11.20 | Zurich Insurance Outperform | Credit Suisse Group | |
| 18.11.20 | ABB (Asea Brown Boveri Underweight | JP Morgan Chase & Co. | |
| 18.11.20 | Credit Suisse (CS buy | Goldman Sachs Group Inc. | |
| 18.11.20 | UBS Neutral | Goldman Sachs Group Inc. | |
| 16.11.20 | ams Underweight | Barclays Capital | |
| 13.11.20 | Zurich Insurance buy | Kepler Cheuvreux | |
| 12.11.20 | LafargeHolcim buy | Goldman Sachs Group Inc. | |
| 12.11.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
| 12.11.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
| 12.11.20 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 12.11.20 | Zurich Insurance buy | UBS AG | |
| 12.11.20 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 11.11.20 | ams Outperform | Credit Suisse Group | |
| 11.11.20 | Givaudan Underperform | Bernstein Research | |
| 10.11.20 | Roche buy | UBS AG | |
| 10.11.20 | UBS overweight | JP Morgan Chase & Co. | |
| 10.11.20 | Credit Suisse (CS Neutral | JP Morgan Chase & Co. | |
| 10.11.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 09.11.20 | ABB (Asea Brown Boveri buy | UBS AG | |
| 09.11.20 | ams buy | Kepler Cheuvreux | |
| 09.11.20 | Givaudan Underperform | Jefferies & Company Inc. | |
| 06.11.20 | ams Underweight | Barclays Capital | |
| 06.11.20 | ams Outperform | Credit Suisse Group | |
| 05.11.20 | Roche overweight | JP Morgan Chase & Co. | |
| 05.11.20 | Swiss Re overweight | JP Morgan Chase & Co. |